Table 2.
Subjects Experiencing Treatment Emergent Serious Adverse Events and Adverse Events Occuring in >1 Subject In Any Cohort by MedRA System Organ Class
Cohort 1 7·5 × 1011vg (N = 5) | Cohort 2 1·5 × 1012vg (N = 5) | Cohort 3 4·7 × 1012vg (N = 5) | Total (N = 15) | |
---|---|---|---|---|
Any adverse event | 5 | 5 | 5 | 15 |
Any serious averse event | 0 | 1a | 0 | 1 |
Gastrointestinal disorders | ||||
Constipation | 1 | 2 | 0 | 3 |
Vomiting | 1 | 1 | 0 | 2 |
Infections and infestations | ||||
Tooth abcess | 2 | 0 | 0 | 2 |
Upper respiratory tract infection | 2 | 0 | 1 | 3 |
Metabolism and nutrition disorders | ||||
Vitamin B12 deficiency | 0 | 2 | 0 | 2 |
Musculoskeletal and connective tissue disorders | ||||
Back pain | 2 | 2 | 0 | 4 |
Musculoskeletal pain | 3 | 0 | 1 | 4 |
Nervous system disorders | ||||
Dizziness | 2 | 0 | 0 | 2 |
Dyskinesia | 2 | 1 | 1 | 4 |
Headache | 5 | 3 | 3 | 11 |
Hypoaesthesia | 3 | 1 | 3 | 7 |
Memory impairment | 2 | 0 | 0 | 2 |
Neuralgia | 2 | 0 | 0 | 2 |
Psychiatric disorders | ||||
Depression | 2 | 1 | 0 | 3 |
Vascular disorders | ||||
Orthostatic hypotension | 2 | 0 | 0 | 2 |
One participant experienced a deep venous thrombosis, pulmonary embolus, and subsequent atrial fibrillation, likely attributed to immobility during the surgery.
MedRA = Medical Dictionary for Regulatory Activities; vg = vector genomes.